{"transactions":[{"id":4627657,"issuer":{"id":183937,"kind":"organization","name":"ADARx Pharmaceuticals, Inc.","symbol":"ADRX"},"owners":[{"id":183964,"kind":"person","name":"MacLeod Alan Robert","position":1,"cik":"0002154450","reported_name":"MacLeod Alan Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-09-28T20:30:20.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":170692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the total shares vest and become exercisable on September 24, 2027 and the remaining shares vest and become exercisable in equal quarterly installments thereafter over a three-year period, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":170692,"derivative":{"exercise_price":17,"expiration_date":"2036-09-23","underlying":"Common Stock","underlying_shares":170692},"source":{"system":"sec-edgar","filing":"0002154450-26-000004","document":"form4-09282026_040905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2154450/000215445026000004/form4-09282026_040905.xml","form_type":"4"}}]}